These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

284 related items for PubMed ID: 498111

  • 1. Comparative antitumor effects of Corynebacterium parvum, Bordetella pertussis, Bacillus Calmette-Guérin, and levamisole alone or in combination with cyclophosphamide in the CaD2 murine mammary adenocarcinoma system.
    Purnell DM, Bartlett GL, Kreider JW, Biro TG, Kontra J.
    Cancer Res; 1979 Dec; 39(12):4838-42. PubMed ID: 498111
    [Abstract] [Full Text] [Related]

  • 2. Effects of dose and schedule of immune stimulant on efficacy of combination Corynebacterium parvum-cyclophosphamide treatment for a murine mammary adenocarcinoma.
    Purnell DM, Bartlett GL, Kreider JW.
    Cancer Res; 1979 Jan; 39(1):1-5. PubMed ID: 761179
    [Abstract] [Full Text] [Related]

  • 3. Comparative effects of Corynebacterium parvum, Brucella abortus extract, Bacillus Calmette-Guérin, glucan, levamisole, and tilorone with or without cyclophosphamide on tumor growth, macrophage production, and macrophage cytotoxicity in a murine mammary tumor model.
    Fisher B, Gebhardt M.
    Cancer Treat Rep; 1978 Nov; 62(11):1919-30. PubMed ID: 728912
    [Abstract] [Full Text] [Related]

  • 4. Corynebacterium parvum and cyclophosphamide as combination treatment for a murine mammary adenocarcinoma.
    Purnell DM, Bartlett GL, Kreider JW, Biro TG.
    Cancer Res; 1977 Apr; 37(4):1137-40. PubMed ID: 844041
    [Abstract] [Full Text] [Related]

  • 5. Conditions for effective Bacillus Calmette-Guérin immunotherapy of postsurgical metastases of 13762A rat mammary adenocarcinoma.
    Kreider JW, Bartlett GL, Boyer CM, Purnell DM.
    Cancer Res; 1979 Mar; 39(3):987-92. PubMed ID: 427785
    [Abstract] [Full Text] [Related]

  • 6. Inhibition of C3H/He mouse mammary tumor growth by combined treatment with cyclophosphamide and polyadenylic-polyuridylic acid.
    Youn JK, Lacour F, Hue G.
    Cancer Res; 1982 Nov; 42(11):4706-11. PubMed ID: 7127305
    [Abstract] [Full Text] [Related]

  • 7. Comparison of the inhibition of tumor growth following local or systemic administration of Corynebacterium parvum or other immunostimulating agents with or without cyclophosphamide.
    Fisher B, Gebhardt M, Linta J, Saffer E.
    Cancer Res; 1978 Sep; 38(9):2679-87. PubMed ID: 679170
    [No Abstract] [Full Text] [Related]

  • 8. Immunotherapy of an established rat mammary adenocarcinoma (13762A) with intratumor injection of Corynebacterium parvum.
    Kreider JW, Bartlett GL, Purnell DM, Webb S.
    Cancer Res; 1978 Mar; 38(3):689-92. PubMed ID: 626972
    [Abstract] [Full Text] [Related]

  • 9. Requirements for successful immunotherapy and chemoimmunotherapy of a murine model of ovarian cancer.
    Vanhaelen CP, Fisher RI.
    Cancer Res; 1981 Mar; 41(3):980-3. PubMed ID: 7193085
    [Abstract] [Full Text] [Related]

  • 10. Preoperative intralesional Bacillus Calmette-Guérin for mammary adenocarcinoma in rats.
    Lee YT.
    Cancer Res; 1977 Oct; 37(10):3679-83. PubMed ID: 908015
    [Abstract] [Full Text] [Related]

  • 11. Correlation of antitumor chemoimmunotherapy with serum inhibition of tumor cell destruction.
    Fisher B, Hanlon J, Gebhardt M, Linta J, Saffer E.
    Cancer Res; 1978 Jan; 38(1):38-41. PubMed ID: 618581
    [Abstract] [Full Text] [Related]

  • 12. Response of disseminated breast cancer to combined modality treatment with chemotherapy and levamisole with or without Bacillus Calmette-Guérin.
    Hortobagyi GN, Yap HY, Blumenschein GR, Gutterman JU, Buzdar AU, Tashima CK, Hersh EM.
    Cancer Treat Rep; 1978 Nov; 62(11):1685-92. PubMed ID: 728894
    [Abstract] [Full Text] [Related]

  • 13. A bladder tumor model response to immunotherapy.
    deKernion JB, Ramming KP, Fraser K.
    Natl Cancer Inst Monogr; 1978 Dec; (49):333. PubMed ID: 748789
    [Abstract] [Full Text] [Related]

  • 14. Destruction of regional lymph node metastases of rat mammary adenocarcinoma 13762A by treatment with Corynebacterium parvum.
    Kreider JW, Bartlett GL, Purnell DM, Webb S.
    Cancer Res; 1978 Dec; 38(12):4522-6. PubMed ID: 719637
    [Abstract] [Full Text] [Related]

  • 15. Further observations on the inhibition of tumor growth by Corynebacterium parvum with cyclophosphamide. III. Effect of C. parvum on cyclophosphamide metabolism.
    Fisher B, Wolmark N, Rubin H.
    J Natl Cancer Inst; 1976 Jul; 57(1):225-6. PubMed ID: 1003505
    [Abstract] [Full Text] [Related]

  • 16. The effect of Corynebacterium parvum in combination with 5-fluorouracil, L-phenylalanine mustard, or methotrexate on the inhibition of tumor growth.
    Fisher B, Rubin H, Saffer E, Wolmark N.
    Cancer Res; 1976 Aug; 36(8):2714-9. PubMed ID: 1277181
    [Abstract] [Full Text] [Related]

  • 17. Mammary tumor growth inhibition in C3H/He mice by long-term Bacillus Calmette-Guérin immunoprophylaxis versus enhancement by primary Bacillus Calmette-Guérin therapy.
    Vaage J.
    Cancer Res; 1983 Dec; 43(12 Pt 1):5778-82. PubMed ID: 6357431
    [Abstract] [Full Text] [Related]

  • 18. Combination chemotherapy plus methanol extracted residue of bacillus Calmette-Guérin or Corynebacterium parvum in stage III lung cancer.
    Bjornsson S, Takita H, Kuberka N, Preisler H, Catane H, Higby D, Henderson E.
    Cancer Treat Rep; 1978 Apr; 62(4):505-10. PubMed ID: 350388
    [Abstract] [Full Text] [Related]

  • 19. Immunotherapy of postoperative metastases of 13762A rat mammary adenocarcinoma: comparative effectiveness of BCG substrains and methods of preparation.
    Kreider JW, Bartlett GL, Purnell DM.
    Cancer; 1980 Aug 01; 46(3):500-7. PubMed ID: 7397623
    [Abstract] [Full Text] [Related]

  • 20. Chemoimmunotherapy of murine mammary adenocarcinomas.
    Ames IH.
    Anticancer Res; 2004 Aug 01; 24(4):2249-56. PubMed ID: 15330169
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.